Ultrasound specialist Edap TMS (NSDQ:EDAP) said it joined a $45 million research consortium led by GE Healthcare (NYSE:GE) to develop new treatments for liver cancer.
Bpifrance, a public investment bank backed by the French government, is putting up $20 million over 5 years for the project, called the Hepatocellular Carcinoma Multi-technological or HECAM.
Help employers find you! Check out all the jobs and post your resume.
